Robin Guo

Robin Guo is currently the Founder of a stealth biotech startup focused on developing novel therapeutic solutions for diabetes and Alzheimer’s disease. Prior to launching this new venture, he spent nearly four years at Andreessen Horowitz, where he most recently served as an Investment Partner. During his extensive tenure at the venture capital firm, Guo operated across multiple disciplines as a software product manager and investor, ultimately serving as a founding team member of the a16z Speedrun startup accelerator. He also helped spin out the firm's dedicated games fund while refining his consumer investing and product management frameworks alongside notable industry figures like Andrew Chen and Josh Lu. Leveraging his early collegiate biomedical technical background, Guo has now transitioned from evaluating application-layer software, artificial intelligence, and gaming investments to actively building a dedicated healthcare enterprise.